Sponsor
Institut de Recherches Cliniques de Montreal
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Institut de Recherches Cliniques de Montreal appears in 71 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownUpdating Preventive and Treatment Guidelines for Hypoglycemia in Individuals Living With Type 1 DiabetesNCT06683391 · lead sponsor · 2025-02-06
RECRUITINGGlycemic Variations During the Menstrual Cycle in Women With Type 1 DiabetesNCT05258292 · lead sponsor · 2022-05-02
RECRUITINGIdentification of Dysglycemia With Continuous Glucose Monitoring to Assess Clinical Evolution in Cystic FibrosisNCT05099939 · lead sponsor · 2021-11-25
RECRUITINGTargeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty AcidsNCT04485871 · lead sponsor · 2019-12-19
RECRUITINGRegistry of Patients Living With Type 1 DiabetesNCT03720197 · lead sponsor · 2019-02-20
RECRUITINGFunctional Mobility and Resistance Exercise for Postmenopausal Females With Type 1 DiabetesNCT07851662 · lead sponsor · 2026-12-01
NOT_YET_RECRUITINGNO-Meal Announcement in Automated Insulin Delivery (Open-source and Commercial) SystemsNCT07758647 · lead sponsor · 2026-10-01
NOT_YET_RECRUITINGFeasibility and Adoption of a Screening Program for T1D Relatives in CanadaNCT07322380 · lead sponsor · 2026-04-05
NOT_YET_RECRUITINGPrevalence and Risk Factors of Metabolic-Associated Hepatic Steatosis in Individuals Living With Type 1 DiabetesNCT07475962 · lead sponsor · 2026-04-01
NOT_YET_RECRUITINGEffect of Ambient Temperature on Blood Glucose and Insulin Absorption in Adults With Type 1 DiabetesNCT07491133 · lead sponsor · 2026-03-01
NOT_YET_RECRUITINGBlood Glucose Target Before and During Exercise in Adults With Type 1 Diabetes Using an Artificial PancreasNCT05821322 · lead sponsor · 2023-07-01
TERMINATEDSafety and Effectiveness of Automated Insulin Delivery (AID) Systems in Physically Active Adults With Type 1 DiabetesNCT05626725 · lead sponsor · 2022-12-01
COMPLETEDLow cArbohydraTe dIeT and aUtomated Insulin Delivery System for Type 1 DiabetEsNCT05449678 · lead sponsor · 2022-09-01
UNKNOWNRestoration of Hypoglycemia Awareness With Home-based High Intensity Interval TrainingNCT04825366 · lead sponsor · 2021-08-03
COMPLETEDPrevention of Mild-to-moderate Hypoglycemia in Type 1 DiabetesNCT04876079 · lead sponsor · 2021-06-01
COMPLETEDCarbohydrates Under Target for Type 1 Diabetes ManagementNCT04758858 · lead sponsor · 2021-03-01
WITHDRAWNVitamin K Supplementation to Reduce Deficiencies in Adults With Cystic FibrosisNCT04496921 · lead sponsor · 2020-08-10
WITHDRAWNAssessment of the Efficacy of the Artificial Pancreas Combined With a Qualitative Meal Size Estimation to Control Postprandial Glucose LevelsNCT04031599 · lead sponsor · 2020-07-10
COMPLETEDIndividualized Carbohydrate Intake Strategy to Improve Blood Glucose ControlNCT03995498 · lead sponsor · 2019-07-01
COMPLETEDInsulin-based Strategies to Prevent Hypoglycemia During Two Types of ExerciseNCT03845114 · lead sponsor · 2019-06-30
COMPLETEDComparison of FiAsp and Aspart During Postprandial Exercise in Adults With Type 1 DiabetesNCT03659799 · lead sponsor · 2019-04-12
COMPLETEDClosed-loop Control of Glucose Levels (Artificial Pancreas) for 12 Days in Adults With Type 1 DiabetesNCT02846831 · lead sponsor · 2019-01-24
COMPLETEDElectrocardiographic Modifications and Spontaneous Hypoglycemic Episodes in Type 1 DiabetesNCT03682250 · lead sponsor · 2018-09-17
TERMINATEDTreatment of Hypoglycemia in Type 1 DiabetesNCT03489967 · lead sponsor · 2018-04-18
COMPLETEDComparison of the Efficacy of Rapid-acting Aspart and Faster Acting Aspart Within the Context of Single-hormone Closed-loop Strategy at Regulating Postprandial Glucose LevelsNCT03335501 · lead sponsor · 2018-04-01
WITHDRAWNClosed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 DiabetesNCT02488616 · lead sponsor · 2018-03-01
WITHDRAWNClosed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 DiabetesNCT02490098 · lead sponsor · 2018-01-01
WITHDRAWNComparison of Blood Pressure Measurement With an Omron HEM-907 Device in a Clinical Setting and a Research SettingNCT03360669 · lead sponsor · 2017-11-27
COMPLETEDSimplification of CF-related Diabetes Screening at HomeNCT03227094 · lead sponsor · 2017-11-13
COMPLETEDCarbohydrate-based Strategies to Prevent Exercise-induced HypoglycemiaNCT03214107 · lead sponsor · 2017-08-03
COMPLETEDClosed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 DiabetesNCT02855307 · lead sponsor · 2016-09-01
COMPLETEDThe Effect of Soluble Fiber to Reduce Post-prandial Glycemic Excursion in Adults With Cystic FibrosisNCT02810691 · lead sponsor · 2016-07-01
COMPLETEDClosed-loop Control of Postprandial Glucose Levels After Meals With Different Macronutrients Content in Adults With Type 1 DiabetesNCT02774876 · lead sponsor · 2016-06-01
COMPLETEDSafety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation - Part 2NCT02798250 · lead sponsor · 2016-06-01
COMPLETEDEvaluating the True Magnitude of HYPOglycemic Events After THE Initiation of SulfonylureaNCT02485132 · lead sponsor · 2016-03-01
TERMINATEDSafety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop OperationNCT02626936 · lead sponsor · 2016-01-01
COMPLETEDInsulin-based Strategies to Prevent Hypoglycemia During ExerciseNCT02631265 · lead sponsor · 2016-01-01
COMPLETEDImpact of a Nutritional Intervention on Type1 Diabetes Adult With Metabolic SyndromeNCT02821585 · lead sponsor · 2016-01-01
COMPLETEDClosed-loop Control of Glucose Levels (Artificial Pancreas) for 24 Hours in Adults With Type 2 Diabetes Under Intensive Insulin TherapyNCT02490085 · lead sponsor · 2015-10-01
COMPLETEDKinetics of YKL-40 Protein in Serum of Cystic Fibrosis PatientsNCT02305784 · lead sponsor · 2015-05-01
COMPLETEDClosed-loop Control of Postprandial Glucose Levels in Adults With Type 1 DiabetesNCT02416765 · lead sponsor · 2015-05-01
COMPLETEDClosed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Type 1 Diabètes Adults With Hypoglycemia Unawareness and Documented Nocturnal HypoglycemiaNCT02282254 · lead sponsor · 2014-10-01
COMPLETEDClosed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Children With Type 1 Diabetes in a Diabetes CampNCT02189694 · lead sponsor · 2014-06-01
COMPLETEDClosed-loop Control of Glucose Levels (Artificial Pancreas) for 60 Hours in Adults With Type 1 DiabetesNCT01966393 · lead sponsor · 2014-04-01
COMPLETEDClosed-loop Control of Glucose Levels (Artificial Pancreas) During Exercise in Adults With Type 1 DiabetesNCT01930110 · lead sponsor · 2014-04-01
COMPLETEDClosed-loop Control of Glucose Levels After Meal Intake in Adults With Type 1 DiabetesNCT01930097 · lead sponsor · 2013-08-01
COMPLETEDClosed-loop Control of Overnight Glucose Levels in Adults and Adolescents With Type 1 DiabetesNCT01905020 · lead sponsor · 2013-07-01
COMPLETEDEffects of an Exercise Program Among CF Patients With DysglycemiaNCT02127957 · lead sponsor · 2013-07-01
COMPLETEDEfficacy of Small Subcutaneous Glucagon Dose to Treat Hypoglycemia in Adults With Type 1 DiabetesNCT01828125 · lead sponsor · 2013-04-01
WITHDRAWNClosed-loop Control of Glucose Levels (Artificial Pancreas) for 24 Hours in Adults and Adolescents With Type 1 DiabetesNCT01754337 · lead sponsor · 2012-12-01
COMPLETEDAdipose Tissue Pre and Post Bariatric SurgeryNCT05304325 · lead sponsor · 2012-04-25
UNKNOWNComparison of Closed-loop Operation After Morning Meal With and Without Carbohydrate CountingNCT01519102 · lead sponsor · 2012-01-01
COMPLETEDExercise Program Combined or Not With Nutritional intErvention in Adults With tyPe 2 DiabetesNCT01186952 · lead sponsor · 2010-09-01
COMPLETEDLevemir-Body Composition and Energy MetabolismNCT00862875 · lead sponsor · 2009-03-01
COMPLETEDHigher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and DiabetesNCT00208221 · lead sponsor · 2006-08-01
TERMINATEDPharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients.NCT00232882 · lead sponsor · 2003-12-01
COMPLETEDClosed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 DiabetesNCT02846857 · lead sponsor
WITHDRAWNClosed-loop Control of Glucose Levels in the Context of Exercise in Adults With Type-1 DiabetesNCT01297946 · lead sponsor
COMPLETEDA Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood SugarNCT07284511 · collaborator · 2026-05-19
RECRUITINGGlycemic Control and Osteohealth in Adults Living With Type 1 DiabetesNCT06158503 · collaborator · 2025-02-01
RECRUITINGDrugs studied in this sponsor's trials
7 mapped RxNorm conceptsThese drug records are connected through ClinicalTrials.gov studies listing Institut de Recherches Cliniques de Montreal as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.
insulin, regular, human12
glucagon5
insulin aspart, human1
placebo1
ramipril1
sotagliflozin1
tirzepatide1
insulin, regular, human RxCUI 253182 · Lead sponsor in 11 linked trial(s) · 1 currently recruiting
12 trials
glucagon RxCUI 4832 · Lead sponsor in 5 linked trial(s) · 0 currently recruiting
5 trials
insulin aspart, human RxCUI 51428 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
placebo RxCUI 8375 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting
1 trial
ramipril RxCUI 35296 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
sotagliflozin RxCUI 2638675 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting
1 trial
tirzepatide RxCUI 2601723 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting
1 trial
Sponsor roles
lead sponsor58
collaborator13
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.